(MENAFN- Straits Research)
Capillary Electrophoresis Market Size & Growth Analysis
The global capillary electrophoresis market size was valued at USD 485.72 million in 2025 and is projected to grow from USD 511.07 million in 2026 to USD 767.84 million by 2034, registering a CAGR of 5.22% during the forecast period from 2026 to 2034. North America dominated the capillary electrophoresis market with a market share of 38.45% in 2025.
Capillary electrophoresis is an analytical separation technique used to separate and analyze charged molecules based on their size, charge, and electrophoretic mobility within a narrow capillary filled with an electrolyte solution. The technique uses an electric field to move molecules through the capillary, enabling the rapid and precise analysis of substances such as proteins, peptides, nucleic acids, pharmaceuticals, ions, and other biomolecules. Capillary electrophoresis offers advantages including high separation efficiency, low sample and reagent consumption, rapid analysis, and automation. The market includes capillary electrophoresis instruments, consumables, reagents, software, and related services used across pharmaceutical and biotechnology companies, clinical laboratories, academic and research institutions, and other analytical applications.
Capillary Electrophoresis Market Key Takeaways
Global Market Size & Growth
2025 Market Size: USD 485.72 Million
2026 Market Size: USD 511.07 Million
2034 Projected Market Size: USD 767.84 Million
Forecast Period: 2026–2034
Base Year: 2025
Market CAGR (2026–2034): 5.22%
Regional Insights
Largest Regional Market (2025): North America
North America Market Share (2025): 38.45%
Fastest-Growing Region: Asia Pacific
Asia Pacific CAGR (2026–2034): 7.91%
Segment Insights
By Product Type Share
Leading Segment: Instrument
Market Share in 2025: 34.2%
By Mode Share
Fastest-Growing Segment: Capillary gel electrophoresis
CAGR: 7.08% (2026–2034)
By Application Share
Leading Segment: Nucleic acid analysis
Market Share in 2025: 24.65%
By End-User Share
Fastest-Growing Segment: Pharmaceutical and biotechnology companies
CAGR: 7.28% (2026–2034)
Download a Free Sample To learn more about this report,
Capillary Electrophoresis Market Trends
Automation and High-Throughput Systems Improve Capillary Electrophoresis Workflows
The capillary electrophoresis market is increasingly moving toward automated, multi-capillary, and high-throughput systems that reduce manual intervention and improve testing efficiency. Automation is particularly valuable in pharmaceutical and biotechnology laboratories, where protein characterization, purity assessment, and quality control require repeatable and quantitative analysis. The integration of advanced detection technologies is also improving sensitivity and enabling laboratories to process more samples within shorter workflows.
In September 2025, SCIEX launched native fluorescence detection for its BioPhase 8800 system, enhancing CE-SDS and cIEF workflows used to assess critical quality attributes of protein therapeutics. The technology improves detection of low-abundance peaks and supports more sensitive characterization of purity, fragmentation, aggregation, and post-translational modifications.
Integration With Genomic and Clinical Testing Expands CE Applications
Capillary electrophoresis is increasingly being integrated into genomic analysis, Sanger sequencing, fragment analysis, clinical diagnostics, and precision medicine workflows. The development of regulatory-compliant instruments and automated systems is helping laboratories use CE for targeted genomic testing alongside its established applications in DNA and protein analysis. This expansion is supported by the growing need for reliable, rapid, and high-resolution molecular analysis in clinical and research environments.
In April 2025, Thermo Fisher Scientific introduced the Applied Biosystems SeqStudio Flex Dx Genetic Analyzer, an IVDR-compliant capillary electrophoresis system designed for clinical and research applications involving Sanger sequencing and fragment analysis in targeted genomic testing. The launch demonstrates the continued integration of CE technology into regulated clinical and genomic workflows.
Capillary Electrophoresis Market Dynamics
Market Drivers
Expansion of Precision Medicine and Genomic Testing Strengthens CE Demand
The growing use of personalized medicine, genomic testing, and molecular diagnostics is supporting demand for capillary electrophoresis. CE enables high-resolution analysis of nucleic acids, proteins, and other biomolecules and remains important for applications such as Sanger sequencing, fragment analysis, genetic testing, and biopharmaceutical characterization. As healthcare systems increasingly adopt targeted therapies and biomarker-driven treatment, laboratories require accurate analytical technologies capable of supporting complex molecular workflows.
In April 2025, Thermo Fisher Scientific launched the Applied Biosystems SeqStudio Flex Dx Genetic Analyzer, an IVDR-compliant capillary electrophoresis platform designed for Sanger sequencing and fragment analysis in clinical and research applications. The launch demonstrates the continued role of CE in targeted genomic testing and precision medicine workflows.
Market Restraints
High Infrastructure and Equipment Costs Limit Access to Advanced CE Systems
Capillary electrophoresis systems can require significant investment in sophisticated instruments, laboratory infrastructure, consumables, maintenance, and trained personnel. Advanced platforms used for genomic and biopharmaceutical analysis may also require specialized technical expertise, creating challenges for smaller laboratories and academic institutions with limited budgets. These financial and operational requirements can slow adoption in emerging markets and restrict access to high-complexity testing capabilities.
In February 2026, Thermo Fisher Scientific emphasized the increasing complexity of modern genomic laboratory workflows and the importance of advanced laboratory capabilities for high-throughput genetic analysis. The continued development of sophisticated sequencing and CE-based platforms highlights the infrastructure and technical expertise required to operate advanced molecular testing laboratories.
Market Opportunity
National Genomics Programs Create New Demand for CE-Based Genetic Analysis
Government-backed genomics programs and private-sector investments in population sequencing are creating opportunities for capillary electrophoresis technologies. Large-scale genomic initiatives require reliable analytical platforms for sequencing, fragment analysis, variant identification, and validation of genetic findings. As countries expand genomic databases and integrate genetic information into clinical research and precision medicine, CE systems can benefit from increased demand for targeted sequencing and confirmatory analysis.
In January 2026, Genomics England continued expanding the use of genomic data through the NHS Genomic Medicine Service, supporting the integration of genomic testing into routine healthcare and research. The expansion of national genomic medicine infrastructure creates additional opportunities for analytical technologies, including capillary electrophoresis systems used in targeted sequencing and genetic analysis.
Market Challenges
Increasing Competition From Next-Generation Sequencing Platforms Pressures CE Adoption
The rapid advancement of next-generation sequencing (NGS) technologies presents a significant challenge for the capillary electrophoresis market. NGS can process large volumes of genetic information simultaneously and is increasingly used for whole-genome, whole-exome, and targeted sequencing. CE manufacturers therefore need to demonstrate advantages in areas such as accuracy, speed, workflow simplicity, cost efficiency, and targeted analysis while integrating their systems with broader genomic workflows.
In May 2026, Illumina expanded its sequencing portfolio with technologies designed to support broader genomic analysis and highly sensitive molecular residual disease research. The continued development of high-throughput sequencing platforms illustrates the competitive pressure CE technologies face as laboratories adopt increasingly comprehensive genomic analysis solutions.
Capillary Electrophoresis Market Segmentation
Product Type Insights
The global market is categorized into instruments, consumables, and software. The consumables segment is dominating the market with the highest revenue, growing at a CAGR of 6.4% during the forecast period. An assay is a technique used in molecular biology, pharmacology, laboratory medicine, and environmental biology for qualitative or quantitative measurement of a target entity's presence, quantity, or functional activity (the analyte). The analyte may be an organic sample, a cell within an organism, a drug, or a biochemical compound. The measured substance is typically the analyte, the assay's target or measure. Typically, the assay measures and expresses an intensive property of the analyte in the appropriate measurement units (e.g., molarity, density, etc.).
Request Customization to receive a tailored report.
Mode Insights
The global market typically includes capillary zone electrophoresis, capillary gel electrophoresis, and capillary electrochromatography. The capillary gel electrophoresis dominates the market, growing at a CAGR of 6.09% during the forecast period. Although capillary gel electrophoresis is at the forefront of developing advanced technology-based products, capillary zone electrophoresis has a wide range of diagnostic applications. Additionally, it is anticipated that capillary zone electrophoresis and capillary gel electrophoresis will actively incorporate diagnostics due to a shift in emphasis toward next-generation sequencing and an increase in the prevalence of infectious diseases and various types of cancer. Compared to other modes, capillary electrochromatography contributes significantly to expanding the global capillary electrophoresis market.
Application Insights
The global market includes nucleic acid and protein analysis. The nucleic acid analysis electrophoresis dominates the market, growing at a CAGR of 6.09% during the forecast period. Nucleic acid analysis generally involves isolating and characterizing the target DNA or RNA sample. Analyses of nucleic acids include purification techniques, hybridization, in situ hybridization, and DNA sequencing. The primary application of capillary electrophoresis is nucleic acid analysis, which includes genotyping, gene expression analysis, epigenetic analysis, and microbiome research.
End-Users Insights
The global market typically includes academic and research institutions, clinical laboratories, pharmaceutical, and biotechnology companies. The academic and research institutions are dominating the market and are expected to reach USD 215 million during the forecast period. In addition, academic and research institutions and clinical laboratories are anticipated to actively incorporate diagnostics due to a shift in emphasis toward next-generation sequencing and a rise in the prevalence of infectious diseases and various cancers. Considering other pharmaceutical and biotechnology companies as capillary electrophoresis market end-users is crucial to the market's expansion.
Speak to an Analyst to discuss market opportunities.
Capillary Electrophoresis Market Regional Overview
North America Capillary Electrophoresis Market Analysis
North America accounted for 38.45% of the global capillary electrophoresis market in 2025, with a market value of USD 0.19 billion. The regional market is projected to grow at a 6.62% CAGR during the forecast period. Growth is supported by advanced pharmaceutical and biotechnology research, increasing adoption of genomic and molecular testing, and strong demand for protein characterization and quality-control technologies. The presence of established analytical instrument manufacturers and well-developed laboratory infrastructure is also supporting regional market expansion.
United States Capillary Electrophoresis Market Insights
The United States is the leading capillary electrophoresis market in North America, supported by its strong pharmaceutical, biotechnology, and life sciences sectors. Increasing research in genomics, personalized medicine, biologics, and genetic testing is creating demand for high-resolution analytical technologies. The country's extensive laboratory infrastructure and continued investment in advanced molecular analysis are further supporting adoption of capillary electrophoresis systems.
Canada Capillary Electrophoresis Market Insights
Canada's capillary electrophoresis market is supported by growing pharmaceutical and biotechnology research and increasing investment in genomic and molecular diagnostics. Research institutions and laboratories are adopting advanced analytical technologies for DNA, RNA, protein, and biomolecule analysis. Growing precision medicine research and improvements in laboratory infrastructure are also contributing to market development.
Unlock Regional Insights to access country-level data, & regional trends.
Europe Capillary Electrophoresis Market Analysis
Europe represented 27.35% of the global capillary electrophoresis market in 2025, with a market value of USD 0.13 billion. The regional market is expected to grow at a 6.38% CAGR during the forecast period. Growth is driven by increasing pharmaceutical and biotechnology research, expanding genomic testing, and rising demand for analytical technologies in biopharmaceutical development. Strong regulatory standards for pharmaceutical quality and the region's established research infrastructure are also supporting the adoption of capillary electrophoresis.
Germany Capillary Electrophoresis Market Insights
Germany's capillary electrophoresis market is supported by its strong pharmaceutical, biotechnology, chemical, and research industries. Increasing demand for analytical testing in drug development, quality control, genomics, and protein characterization is supporting the use of CE systems. The country's advanced laboratory infrastructure and focus on precision medicine are also contributing to market growth.
United Kingdom Capillary Electrophoresis Market Insights
The United Kingdom's capillary electrophoresis market is driven by strong life sciences research, genomic medicine initiatives, and pharmaceutical development. Increasing use of molecular diagnostics and genetic analysis is creating demand for high-precision analytical technologies. Government-backed genomics programs and investments in biotechnology research are further supporting the adoption of capillary electrophoresis in clinical and research laboratories.
Asia Pacific Capillary Electrophoresis Market Analysis
Asia Pacific accounted for 22.8% of the global capillary electrophoresis market in 2025, with a market value of USD 0.11 billion. The regional market is projected to grow at a 7.91% CAGR, the highest among the major regions. Growth is supported by expanding pharmaceutical and biotechnology industries, increasing healthcare expenditure, and growing adoption of genomic and molecular diagnostics. Rising research activity in biologics, personalized medicine, and genetic testing is also creating opportunities for CE instruments and consumables.
Japan Capillary Electrophoresis Market Insights
Japan's capillary electrophoresis market is supported by its advanced pharmaceutical, biotechnology, healthcare, and academic research sectors. Increasing research into genomics, biologics, and personalized medicine is driving demand for high-resolution analytical technologies. The country's strong focus on laboratory automation and advanced molecular testing is also supporting the use of capillary electrophoresis systems.
China Capillary Electrophoresis Market Insights
China represents a major growth market for capillary electrophoresis, supported by the expansion of its pharmaceutical and biotechnology industries and increasing investment in life sciences research. Growing genomic testing, drug development, and biopharmaceutical manufacturing are creating demand for analytical technologies. Improvements in laboratory infrastructure and increasing adoption of advanced molecular testing are expected to further support market expansion.
Latin America Capillary Electrophoresis Market Analysis
Latin America accounted for 6.25% of the global capillary electrophoresis market in 2025, with a market value of USD 0.03 billion. The regional market is expected to grow at a 6.71% CAGR during the forecast period. Growth is supported by expanding pharmaceutical research, increasing healthcare investment, and greater adoption of molecular and genetic testing. Improvements in laboratory infrastructure and growing demand for advanced analytical technologies are also creating opportunities across the region.
Brazil Capillary Electrophoresis Market Insights
Brazil's capillary electrophoresis market is supported by its expanding pharmaceutical, biotechnology, healthcare, and academic research sectors. Increasing investment in genetic testing, molecular diagnostics, and biopharmaceutical research is creating demand for advanced analytical systems. Improvements in laboratory capabilities and growing interest in precision medicine are also supporting the adoption of capillary electrophoresis.
Middle East and Africa Capillary Electrophoresis Market Analysis
The Middle East and Africa accounted for 5.15% of the global capillary electrophoresis market in 2025, with a market value of USD 0.03 billion. The regional market is projected to grow at a 6.29% CAGR. Growth is supported by healthcare infrastructure development, increasing pharmaceutical research, and growing adoption of molecular diagnostics and genomic testing. Investments in advanced laboratories and life sciences research are also creating opportunities for analytical technologies.
UAE Capillary Electrophoresis Market Insights
The UAE's capillary electrophoresis market is supported by investments in advanced healthcare infrastructure, pharmaceutical research, biotechnology, and diagnostic services. The country's development as a regional healthcare and life sciences hub is increasing demand for sophisticated laboratory technologies. Growing adoption of molecular diagnostics, genetic testing, and precision medicine is also expected to support the market.
Competitive Landscape
The capillary electrophoresis market is competitive, with leading companies focusing on analytical instruments, reagents, consumables, molecular analysis, protein characterization, and laboratory automation. Key market participants include QIAGEN, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher, Bio-Techne, PerkinElmer Inc., Merck KGaA, Shimadzu Corporation, and Hitachi Ltd. Companies are strengthening their market positions through product development, advanced analytical workflows, research collaborations, and expansion of applications across pharmaceutical, biotechnology, clinical, and research laboratories.
Bio-Techne - Emerging Market Player
Bio-Techne is a prominent life sciences company providing recombinant proteins, antibodies, immunoassays, protein analysis tools, and analytical solutions used across biopharmaceutical research and molecular biology. Its portfolio supports applications including protein characterization, biomarker research, cell and gene therapy development, and quality assessment. Through its ProteinSimple business, Bio-Techne also offers automated capillary-based protein analysis technologies, including the Wes, Jess, and Maurice platforms, which help laboratories perform Western blotting, capillary isoelectric focusing, and related protein characterization workflows.
List of Key and Emerging Players in Capillary Electrophoresis Market
QIAGEN
Thermo Fisher Scientific Inc.
Agilent Technologies Inc.
Bio-Rad Laboratories Inc.
Danaher
Bio-Techne
PerkinElmer Inc.
Merck KGaA
Shimadzu Corporation
Hitachi Ltd.
Teledyne Technologies Incorporated
Helena Laboratories
BiOptic Inc.
LABGENE Scientific SA
Helena Laboratories
Promega Corporation
BiOptic Inc.
LABGENE Scientific SA.
Key Industry Developments
May 2026: SCIEX expanded its capillary electrophoresis portfolio with next-generation analytical systems designed to improve sensitivity, automation, and throughput for biopharmaceutical characterization and life science research.
February 2026: Agilent Technologies introduced advanced capillary electrophoresis solutions featuring enhanced data analysis capabilities and improved reproducibility for pharmaceutical and clinical laboratories.
October 2025: Thermo Fisher Scientific launched upgraded capillary electrophoresis instruments with integrated automation and high-resolution separation technologies to accelerate genomic and proteomic workflows.
June 2025: Bio-Rad Laboratories expanded its electrophoresis product portfolio with enhanced capillary-based platforms for nucleic acid and protein analysis in research and diagnostic applications.
Report Scope
Comments
No comment